Madam Therapeutics

Madam Therapeutics has become member of the BEAM Alliance

The BEAM Alliance represents biopharmaceutical companies from Europe innovating in Anti-Microbial resistance research. BEAM works to improve the regulatory, investment, and commercial environments in Europe for research, development, approval and market viability of new products combating antimicrobial resistance.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.